RS60150B1 - Medicinska kompozicija koja obuhvata diamino heterociklično jedinjenje karboksamida kao aktivni sastojak - Google Patents
Medicinska kompozicija koja obuhvata diamino heterociklično jedinjenje karboksamida kao aktivni sastojakInfo
- Publication number
- RS60150B1 RS60150B1 RS20200432A RSP20200432A RS60150B1 RS 60150 B1 RS60150 B1 RS 60150B1 RS 20200432 A RS20200432 A RS 20200432A RS P20200432 A RSP20200432 A RS P20200432A RS 60150 B1 RS60150 B1 RS 60150B1
- Authority
- RS
- Serbia
- Prior art keywords
- active ingredient
- medicinal composition
- carboxamide compound
- heterocyclic carboxamide
- diamino heterocyclic
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- -1 heterocyclic carboxamide compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014019226 | 2014-02-04 | ||
| EP15746276.3A EP3103453B1 (en) | 2014-02-04 | 2015-02-03 | Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient |
| PCT/JP2015/053018 WO2015119122A1 (ja) | 2014-02-04 | 2015-02-03 | ジアミノヘテロ環カルボキサミド化合物を有効成分とする医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60150B1 true RS60150B1 (sr) | 2020-05-29 |
Family
ID=53777926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200432A RS60150B1 (sr) | 2014-02-04 | 2015-02-03 | Medicinska kompozicija koja obuhvata diamino heterociklično jedinjenje karboksamida kao aktivni sastojak |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US11045468B2 (sr) |
| EP (1) | EP3103453B1 (sr) |
| JP (1) | JP6390626B2 (sr) |
| KR (1) | KR102322338B1 (sr) |
| CN (3) | CN116509866A (sr) |
| AU (1) | AU2015215578B2 (sr) |
| BR (1) | BR112016017897A8 (sr) |
| CA (1) | CA2938818C (sr) |
| CY (1) | CY1122968T1 (sr) |
| DK (1) | DK3103453T3 (sr) |
| EA (1) | EA033304B1 (sr) |
| ES (1) | ES2788390T3 (sr) |
| HR (1) | HRP20200662T1 (sr) |
| HU (1) | HUE049437T2 (sr) |
| IL (1) | IL247077B (sr) |
| LT (1) | LT3103453T (sr) |
| ME (1) | ME03775B (sr) |
| MX (1) | MX363543B (sr) |
| MY (1) | MY193536A (sr) |
| PH (1) | PH12016501527B1 (sr) |
| PL (1) | PL3103453T3 (sr) |
| PT (1) | PT3103453T (sr) |
| RS (1) | RS60150B1 (sr) |
| SG (1) | SG11201606413RA (sr) |
| SI (1) | SI3103453T1 (sr) |
| TW (1) | TWI655945B (sr) |
| UA (1) | UA120607C2 (sr) |
| WO (1) | WO2015119122A1 (sr) |
| ZA (1) | ZA201605379B (sr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3103453B1 (en) * | 2014-02-04 | 2020-04-01 | Astellas Pharma Inc. | Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient |
| PL3318259T3 (pl) * | 2015-07-03 | 2023-05-02 | Astellas Pharma Inc. | Stabilna kompozycja farmaceutyczna do podawania doustnego |
| US10744134B2 (en) | 2015-11-04 | 2020-08-18 | Astellas Pharma Inc. | Pharmaceutical composition for cancer immunotherapy and/or immunological activation containing diamino heterocyclic carboxamide compound as active ingredient |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| JP2023500906A (ja) | 2019-11-08 | 2023-01-11 | インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） | キナーゼ阻害剤に対する獲得抵抗性を有するがんの処置方法 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2022220227A1 (ja) * | 2021-04-14 | 2022-10-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | テトラヒドロピリドピリミジン化合物 |
| WO2023129667A1 (en) | 2021-12-30 | 2023-07-06 | Biomea Fusion, Inc. | Pyrazine compounds as inhibitors of flt3 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110110923A1 (en) * | 2008-02-12 | 2011-05-12 | The Brigham And Women's Hospital, Inc. | Fish assay for eml4 and alk fusion in lung cancer |
| MX2010010272A (es) * | 2008-03-19 | 2011-05-25 | Chembridge Corp | Nuevos inhibidores de tirosina quinasa. |
| UY31800A (es) * | 2008-05-05 | 2009-11-10 | Smithkline Beckman Corp | Metodo de tratamiento de cancer usando un inhibidor de cmet y axl y un inhibidor de erbb |
| EP3009428B1 (en) * | 2009-05-08 | 2018-02-21 | Astellas Pharma Inc. | Diamino heterocyclic carboxamide compound |
| CN102408411B (zh) * | 2011-09-19 | 2014-10-22 | 北京康辰药业股份有限公司 | 一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用 |
| CA2856411A1 (en) * | 2011-11-21 | 2013-05-30 | Immunogen, Inc. | Method of treatment of tumors that are resistant to egfr therapies by egfr antibody cytotoxic agent conjugate |
| UA113204C2 (xx) | 2012-04-02 | 2016-12-26 | Селективна екстракція хлориду калію з відхідного шенітового розчину з використанням тартратної кислоти як безпечного м'якого екстрагента, придатного до рециркуляції | |
| MX361088B (es) * | 2012-11-21 | 2018-11-26 | Janssen Biotech Inc | Anticuerpos del receptor del factor de crecimiento epidérmico aislado/del receptor del factor de crecimiento de hepatocitos (egfr/c-met) biespecíficos. |
| EP3103453B1 (en) * | 2014-02-04 | 2020-04-01 | Astellas Pharma Inc. | Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient |
| WO2015127234A1 (en) * | 2014-02-20 | 2015-08-27 | Board Of Regents, The University Of Texas System | Use of ibrutinib to treat egfr mutant cancer |
| PL3318259T3 (pl) * | 2015-07-03 | 2023-05-02 | Astellas Pharma Inc. | Stabilna kompozycja farmaceutyczna do podawania doustnego |
-
2015
- 2015-02-03 EP EP15746276.3A patent/EP3103453B1/en active Active
- 2015-02-03 KR KR1020167022660A patent/KR102322338B1/ko active IP Right Grant
- 2015-02-03 SG SG11201606413RA patent/SG11201606413RA/en unknown
- 2015-02-03 LT LTEP15746276.3T patent/LT3103453T/lt unknown
- 2015-02-03 MY MYPI2016702813A patent/MY193536A/en unknown
- 2015-02-03 ME MEP-2020-77A patent/ME03775B/me unknown
- 2015-02-03 WO PCT/JP2015/053018 patent/WO2015119122A1/ja active Application Filing
- 2015-02-03 AU AU2015215578A patent/AU2015215578B2/en active Active
- 2015-02-03 RS RS20200432A patent/RS60150B1/sr unknown
- 2015-02-03 CN CN202310702543.7A patent/CN116509866A/zh active Pending
- 2015-02-03 BR BR112016017897A patent/BR112016017897A8/pt active IP Right Grant
- 2015-02-03 EA EA201691570A patent/EA033304B1/ru not_active IP Right Cessation
- 2015-02-03 CN CN202110880188.3A patent/CN113425727A/zh active Pending
- 2015-02-03 UA UAA201609187A patent/UA120607C2/uk unknown
- 2015-02-03 ES ES15746276T patent/ES2788390T3/es active Active
- 2015-02-03 SI SI201531179T patent/SI3103453T1/sl unknown
- 2015-02-03 DK DK15746276.3T patent/DK3103453T3/da active
- 2015-02-03 MX MX2016010134A patent/MX363543B/es unknown
- 2015-02-03 PT PT157462763T patent/PT3103453T/pt unknown
- 2015-02-03 US US15/116,736 patent/US11045468B2/en active Active
- 2015-02-03 HU HUE15746276A patent/HUE049437T2/hu unknown
- 2015-02-03 CA CA2938818A patent/CA2938818C/en active Active
- 2015-02-03 CN CN201580006772.9A patent/CN105939714A/zh active Pending
- 2015-02-03 JP JP2015560991A patent/JP6390626B2/ja active Active
- 2015-02-03 PL PL15746276T patent/PL3103453T3/pl unknown
- 2015-02-04 TW TW104103756A patent/TWI655945B/zh active
-
2016
- 2016-08-02 IL IL247077A patent/IL247077B/en active IP Right Grant
- 2016-08-03 PH PH12016501527A patent/PH12016501527B1/en unknown
- 2016-08-04 ZA ZA2016/05379A patent/ZA201605379B/en unknown
-
2020
- 2020-04-24 HR HRP20200662TT patent/HRP20200662T1/hr unknown
- 2020-04-28 CY CY20201100384T patent/CY1122968T1/el unknown
-
2021
- 2021-05-21 US US17/327,337 patent/US11925638B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219432A1 (zh) | 以嘧啶化合物爲有效成分的醫藥組合物 | |
| IL247062A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical preparations containing them | |
| ZA201605379B (en) | Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
| IL253538B (en) | Heterocyclic compound and pharmaceutical compound containing it | |
| IL248090B (en) | Solid pharmaceutical preparations containing biopterin derivatives and their uses | |
| EP2987786A4 (en) | AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| IL304109A (en) | Pharmaceutical preparations containing spinamide | |
| HK1243927A1 (zh) | 含有茶皂醇衍生物作爲活性成分的組合物 | |
| IL249010A0 (en) | A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient | |
| SG11201610636VA (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| SG11201608845PA (en) | Cosmetic composition containing mentha haplocalyx as active ingredient | |
| EP3372231A4 (en) | PHARMACEUTICAL COMPOSITION FOR ANTICANCER IMMUNOTHERAPY AND / OR FOR IMMUNOSTIMULATION, CONTAINING AS ACTIVE PRINCIPLE A HETEROCYCLIC DIAMINO CARBOXAMIDE COMPOUND | |
| HUE053974T2 (hu) | Szemészeti gyógyászati készítmény | |
| IL252663A0 (en) | A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient | |
| EP3120848A4 (en) | Therapeutic/preventive agent containing coumarin derivative as active ingredient | |
| IL252664A0 (en) | A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient | |
| LT3558261T (lt) | Farmacinės kompozicijos, apimančios safinamidą |